Evidence mapPaperPMID 40333269Full record

ReviewVaccines2025

The Evolution of Annual Immunization Recommendations Against Influenza in Italy: The Path to Precision Vaccination.

Sara Boccalini, Chiara de Waure, Linda Martorella, Paolo Orlando, Paolo Bonanni, Angela Bechini

Abstract readReview
In one paragraph

Review in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara BoccaliniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-9695-7549
Chiara de WaureDepartment of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.ORCID 0000-0002-4346-1494
Linda MartorellaDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.
Paolo OrlandoDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.
Paolo BonanniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-2875-3744
Angela BechiniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-6013-8779

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza vaccination is the health intervention that best guarantees protection against seasonal influenza. Every year, the Ministry of Health issues a document (namely a circular) containing recommendations for the use of available vaccines to prevent and control influenza. A review of the Ministerial Circulars released by the Italian Ministry of Health was conducted with the aim of assessing the evolution over time of the vaccination target recipients, the vaccines that can be used in the following influenza season, and the indications of use for age and appropriateness. Changes have emerged regarding these issues. In fact, over time, the vaccination offer has been extended to children between 6 months and 6 years of age, to adults aged 60-64 years, and to women in any trimester of pregnancy and postpartum. In parallel, from the 2018-2019 season, following the availability of new vaccines, the concept of vaccine appropriateness was introduced to the recommendations, i.e., the choice of the most appropriate vaccine for each subject to be vaccinated. The last circulars introduced the indication of the type of vaccine that can be administered for each target category and the recommendation to use adjuvanted and high-dose vaccines for adults aged ≥ 65 years. The annual recommendations provided by the Italian Ministry of Health, resultantly, are increasingly precise, emphasizing the importance of the concept of appropriateness and outlining the path to precision vaccination. To achieve maximum value in terms of clinical efficacy and community benefits, this concept should continue to be considered as a basis for the development of future recommendations, as it addresses a critical public health issue related to vaccination.

Indexed as

adjuvanted vaccineappropriatenesscell-based vaccinechildrenelderlyhigh dose vaccineinfluenza live-attenuated vaccinepregnancyrisk groupvaccine

Identifiers

PMID40333269
PMCPMC12031309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.